Invests in ViAqua Therapeutics, a biotechnology company based in Haifa, Israel
- ViAqua develops solutions to improve animal health in aquaculture
- Thai Union joins other industry-leading strategic and financial partners in backing the start-up
BANGKOK – June 10, 2021 – Thai Union Group PCL has invested in biotechnology company ViAqua Therapeuticsthrough its venture fund, joining other industry-leading strategic and financial partners in backing the start-up.
ViAqua, based in Haifa, Israel, is a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture. ViAqua’s first product is a feed supplement for enhanced health management in shrimp, including prevalent and devastating diseases which pose major challenges and are widespread in shrimp. Thiraphong Chansiri, President and CEO of Thai Union said, “Disease prevention is a primary concern in the aquaculture sector and ViAqua has a promising technology platform to help manage the health of shrimp and other species. Thai Union is looking forward to supporting ViAqua as they help the global aquaculture industry address this challenge.”
Read more in Thai Union’s press release here.